Report: NIH Employees Receiving 3rd Party ‘Royalties’

In Washington, the pharmaceutical lobby—otherwise known as big pharma—wields a big stick in terms of its influence on Capitol Hill. Adam Andrzejewski is CEO of and he has been keeping an eye on things. NTD spoke with him to learn more.

ntd newsletter icon
Sign up for NTD Daily
What you need to know, summarized in one email.
Stay informed with accurate news you can trust.
By registering for the newsletter, you agree to the Privacy Policy.